Free Cash Flow (Quarterly) Chart

View Free Cash Flow (Quarterly) for IPSC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow (Quarterly) Chart
Start Trial

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -20.53M
March 31, 2026 -25.83M
December 31, 2025 -15.94M
September 30, 2025 -25.78M
June 30, 2025 -27.91M
March 31, 2025 -35.10M
December 31, 2024 -24.38M
September 30, 2024 -27.53M
June 30, 2024 -27.60M
March 31, 2024 -30.79M
December 31, 2023 -27.21M
September 30, 2023 -16.91M
June 30, 2023 -23.75M
Date Value
March 31, 2023 -34.43M
December 31, 2022 -29.30M
September 30, 2022 -34.18M
June 30, 2022 -36.14M
March 31, 2022 82.56M
December 31, 2021 -41.20M
September 30, 2021 -39.84M
June 30, 2021 -29.65M
March 31, 2021 -24.06M
December 31, 2020 -16.63M
September 30, 2020 -13.73M
June 30, 2020 -11.15M
March 31, 2020 -9.583M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
Tenax Therapeutics, Inc. -14.15M
Manhattan Scientifics, Inc. --
Exicure, Inc. -0.887M
Absci Corp. -27.56M
Celularity, Inc. -5.103M